What is the standard approach to managing fistulas in Crohn's disease?

• A. Surgery is always required before medical therapy
• B. Antibiotics alone are sufficient
• C. Medical therapy to reduce inflammation (anti-TNF, immunomodulators) and antibiotics for abscess/fistula; surgical intervention if complex or nonresponsive
• D. No treatment; watchful waiting

Answer: (C)

Treating fistulas in Crohn’s disease focuses on controlling the underlying inflammation while also addressing infection in the fistula tract. Using anti-inflammatory biologic therapy such as anti-TNF agents (for example, infliximab or adalimumab) along with immunomodulators helps reduce transmural inflammation throughout the bowel, which is essential for fistula healing. Antibiotics (like metronidazole or ciprofloxacin) are used to manage abscess formation and infection and can aid in draining and healing the tract, especially when an abscess is present.

Surgery is not the first step. It’s reserved for complex or high-output fistulas, when there is persistent drainage despite medical therapy, or when abscesses require drainage and cannot be controlled medically. The best approach is a coordinated plan that combines medical therapy to suppress disease activity with surgical intervention when necessary to manage complications or facilitate healing.